Drug Resistance to Topoisomerase Directed Chemotherapy in Human Multiple Myeloma
Human multiple myeloma is an incurable hematological malignancy characterized by the proliferation of plasma cells in the bone marrow. Myeloma represents approximately 20% of all blood cancers. In this research we have explored examples of both intrinsic and acquired drug resistance in myeloma. Topo...
Main Author: | Turner, Joel G |
---|---|
Format: | Others |
Published: |
Scholar Commons
2008
|
Subjects: | |
Online Access: | https://scholarcommons.usf.edu/etd/539 https://scholarcommons.usf.edu/cgi/viewcontent.cgi?article=1538&context=etd |
Similar Items
-
Efflux of sphingomyelin, cholesterol, and phosphatidylcholine by ABCG1
by: Aya Kobayashi, et al.
Published: (2006-08-01) -
Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro
by: Yuqi Yang, et al.
Published: (2020-05-01) -
Rôle du domaine extracellulaire d’ABCG2 dans l’homéostasie des porphyrines
by: Desuzinges-Mandon, Elodie
Published: (2010) -
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells
by: Pranav Gupta, et al.
Published: (2018-02-01) -
CRM1 Inhibitors for Antiviral Therapy
by: Cynthia Mathew, et al.
Published: (2017-06-01)